Montag & Associates’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $77.5K | Hold |
262
| – | – | ﹤0.01% | 532 |
|
|
2025
Q4 | $71.7K | Buy |
262
+18
| +7% | +$4.89K | ﹤0.01% | 551 |
|
|
2025
Q3 | $65.9K | Buy |
244
+19
| +8% | +$5.17K | ﹤0.01% | 547 |
|
|
2025
Q2 | $62K | Sell |
225
-227
| -50% | -$61.7K | ﹤0.01% | 544 |
|
|
2025
Q1 | $120K | Buy |
452
+22
| +5% | +$5.43K | 0.01% | 477 |
|
|
2024
Q4 | $102K | Sell |
430
-268
| -38% | -$61.6K | ﹤0.01% | 494 |
|
|
2024
Q3 | $154K | Hold |
698
| – | – | 0.01% | 452 |
|
|
2024
Q2 | $137K | Buy |
698
+268
| +62% | +$55.4K | 0.01% | 453 |
|
|
2024
Q1 | $92.6K | Hold |
430
| – | – | ﹤0.01% | 498 |
|
|
2023
Q4 | $92.8K | Buy |
430
+90
| +26% | +$19.2K | 0.01% | 481 |
|
|
2023
Q3 | $68.1K | Hold |
340
| – | – | ﹤0.01% | 504 |
|
|
2023
Q2 | $63K | Buy |
340
+90
| +36% | +$16.6K | ﹤0.01% | 528 |
|
|
2023
Q1 | $47.9K | Hold |
250
| – | – | ﹤0.01% | 563 |
|
|
2022
Q4 | $43.2K | Hold |
250
| – | – | ﹤0.01% | 567 |
|
|
2022
Q3 | $44K | Hold |
250
| – | – | ﹤0.01% | 558 |
|
|
2022
Q2 | $51K | Hold |
250
| – | – | ﹤0.01% | 525 |
|
|
2022
Q1 | $59K | Hold |
250
| – | – | ﹤0.01% | 533 |
|
|
2021
Q4 | $57K | Hold |
250
| – | – | ﹤0.01% | 548 |
|
|
2021
Q3 | $48K | Hold |
250
| – | – | ﹤0.01% | 567 |
|
|
2021
Q2 | $53K | Hold |
250
| – | – | ﹤0.01% | 543 |
|
|
2021
Q1 | $51K | Hold |
250
| – | – | ﹤0.01% | 561 |
|
|
2020
Q4 | $46K | Buy |
+250
| New | +$42.5K | ﹤0.01% | 548 |
|
|
2019
Q1 | – | Sell |
-2,902
| Closed | -$546K | – | 309 |
|
|
2018
Q4 | $546K | Buy |
2,902
+376
| +15% | +$69.4K | 0.06% | 196 |
|
|
2018
Q3 | $430K | Hold |
2,526
| – | – | 0.04% | 250 |
|
|
2018
Q2 | $414K | Hold |
2,526
| – | – | 0.04% | 224 |
|
|
2018
Q1 | $409K | Hold |
2,526
| – | – | 0.04% | 225 |
|
|
2017
Q4 | $369K | Sell |
2,526
-4,700
| -65% | -$669K | 0.04% | 231 |
|
|
2017
Q3 | $980K | Sell |
7,226
-100
| -1% | -$12.6K | 0.11% | 159 |
|
|
2017
Q2 | $918K | Buy |
7,326
+1,829
| +33% | +$219K | 0.1% | 146 |
|
|
2017
Q1 | $653K | Buy |
5,497
+3,615
| +192% | +$435K | 0.07% | 167 |
|
|
2016
Q4 | $217K | Buy |
+1,882
| New | +$209K | 0.03% | 228 |
|
Other funds holding CME
VCM
VPM
Montag & Associates's CME Position: Q1 2026 in Review
Montag & Associates held its CME Group (CME) position steady in Q1 2026 at 262 shares worth $77.5K. The position accounts for ﹤0.01% of the portfolio, ranked #532.
Montag & Associates first reported a position in CME in Q4 2016 and has held it in 31 quarters since. The position peaked at $980K in Q3 2017. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Montag & Associates held 262 shares of CME Group worth $77.5K as of Q1 2026.
- Montag & Associates left its CME Group share count unchanged in Q1 2026.
- CME Group made up ﹤0.01% of Montag & Associates's portfolio in Q1 2026, its #532 holding.
- Montag & Associates first reported a position in CME Group in Q4 2016 and has held it in 31 quarters since.
- Montag & Associates's CME Group position peaked at $980K in Q3 2017.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.